gtglabs.com (GENE) - Total volume dodolan perusahaan

Genetic Technologies relies on a sovereign development cycle, rendering it a resilient defensive asset regardless of the global economy. Patent protection and stringent medical regulations create significant barriers to entry for new players. Diagnostic efficiency is supported by optimized express logistics for biological samples. The company's aggregated sales demonstrate revenue dynamics where 0.01 represents the latest level value.

GENE Genetic Technologies Limited: Pendapatan perusahaan ing interval 04.07.2022 - 26.10.2024

Rincian analitis perusahaan Genetic Technologies Ltd (GENE)

- nilai pasar lan prakiraan target analis:

Bagan bursa GTG Labs|GENE - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Kapitalisasi pasar Genetic Technologies Limited|GENE - Nilai Perusahaan

- data nilai buku modal saham:

Nilai Aset Bersih saben Saham Genetic Technologies|GENE - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku gtglabs.com|GENE - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Utang marang Modal Genetic Technologies|GENE - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal GTG Labs|GENE - Gunggung utang perusahaan|Utang-utang marang aset resik Genetic Technologies Limited|GENE - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Genetic Technologies|Rasio jangkoan perantara gtglabs.com

- data bathi bisnis lan rasio investasi:

GENE - Penghasilan resik|Bathi resik mangsa ngarep Genetic Technologies|GENE - Pangali P/E|Rasio prakiraan rega marang bathi GTG Labs|GENE - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Genetic Technologies Limited|GENE - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Genetic Technologies|GENE - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan gtglabs.com|GENE - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Genetic Technologies

- indikator volume dodolan lan pendapatan:

GENE - Pendapatan perusahaan|Prakiraan pendapatan perusahaan GTG Labs|GENE - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Genetic Technologies Limited

Ringkesan analisis perusahaan:Genetic Technologies

Produk asli Genetic Technologies Limited

The overall sales dynamics of Genetic Technologies (GENE) reflect the efficiency of scaling the business through the licensing of genetic tests to third-party laboratories. This indicator captures actual cash inflows from service sales, allowing for an assessment of real capital inflow and the risk of overpaying for the asset at the cycle peak, which is critical for confirming the issuer's financial stability.

Pesaing wigati